(Q40312685)

English

Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia

scientific article published on June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Differential effects of peroxisome proliferator-activated receptor ligands and sulfonylurea plus statin treatment on plasma concentrations of adipokines in type 2 diabetes with dyslipidemia (English)

1 reference

Europe PubMed Central

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Yin WH

1

1 reference

Europe PubMed Central

19 September 2017

Jen HL

2

1 reference

Europe PubMed Central

19 September 2017

Chen JW

3

1 reference

Europe PubMed Central

19 September 2017

Lin SJ

4

1 reference

Europe PubMed Central

19 September 2017

Young MS

5

1 reference

Europe PubMed Central

19 September 2017

publication date

1 June 2006

1 reference

Europe PubMed Central

19 September 2017

Diabetes and Metabolism

1 reference

Europe PubMed Central

19 September 2017

32

1 reference

Europe PubMed Central

19 September 2017

3

1 reference

Europe PubMed Central

19 September 2017

229-235

1 reference

Europe PubMed Central

19 September 2017

Obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of adiponectin causes insulin resistance and neointimal formation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptors in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARs as Therapeutic Targets: Reverse Cardiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970273-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1262-3636(07)70273-2

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40312685&oldid=1895001954"